For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
COVID-19 News - Japan  Jan 14, 2023  1 year, 10 months, 1 week, 1 day, 11 hours, 52 minutes ago

COVID-19 News: COVID-19 Deaths Continue To Rise In Japan. 503 Deaths In Last 24 Hours And 740,256 Japanese Are Currently Hospitalized Due To COVID-19!

1966 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: COVID-19 Deaths Continue To Rise In Japan. 503 Deaths In Last 24 Hours And 740,256 Japanese Are Currently Hospitalized Due To COVID-19!
COVID-19 News - Japan  Jan 14, 2023  1 year, 10 months, 1 week, 1 day, 11 hours, 52 minutes ago
COVID-19 News: Japan, one of the few countries that boast high vaccination and booster rates involving the mRNA vaccines from the West is going through an unprecedented COVID-19 crisis as death rates continue to rise since November 2022, with more than 503 COVID-19 deaths reported in the last 24 hours according to official sources.
https://covid19.mhlw.go.jp/extensions/public/en/index.html
 
https://mainichi.jp/english/covid19
 


However, in reality, the actual daily death rates could be as high as 4 to 5-fold not including excess deaths which is another growing concern as well!
 
While many Western experts and authorities are saying that the COVID-19 pandemic is nearly over and that the new emerging SARS-Cov-2 variants are mild, the truth far from it.
 
What is more alarming however is that at this given time, there are almost three quarter million or 740,256 Japanese hospitalized due to COVID-19!
 
I doubt if these sick Japanese individuals are being hospitalized for some sexual fetish reasons but rather the new SARS-CoV-2 variants and sub-lineages in circulation since November 2022 are indeed causing disease severity and are not mild as claimed!
 
We are also not talking about the XB.1.5 or Kraken variant that has only just appeared in Japan and is still very low in circulation and is not expected to drive disease severity.
 
Rather what is driving the deaths and severity in Japan is a number of BF.7 and BF. 5 sub-lineages and also some BA.5.2 sub-lineages, some of which can also be found in China, Hong Kong and even South Korea and Taiwan and what is being referred to as the East Asian variants including BF.7.14,BF.7.41, BF.5.1, BF.5.2, BA.5.2.48. BA.5.2.49 and also the new BF.7.15.
https://outbreak.info/location-reports?xmin=2022-07-14&xmax=2023-01-14&loc=JPN
 
https://www.thailandmedical.news/news/covid-19-news-another-new-worrisome-bf-variant-emerges-in-japan-ie-bf-7-15,-that-joins-other-dangerous-east-asian-variants-bf-7-14,-bf-5-1-and-bf-5-2
 
https://www.thailandmedical.news/news/breaking-covid-19-news-researchers-concerned-about-new-ba-5-2-1-with-mutations-in-the-orf9b-in-japan-may-be-driving-disease-severity-and-deaths
 
https://www.thailandmedical.news/news/breaking-covid-19-news-is-the-new-bf-5-variant-with-orf1a-i2873v-mutation-driving-covid-19-deaths-in-japan-urgent-research-warranted
 
/> The new BF.7.15 sub-lineages carries the spike mutation S:G257D and also the ORF1a:A1812V mutation.
https://github.com/cov-lineages/pango-designation/issues/1358
 
This variant has also been found in China and in reality almost all the variants driving disease severity can be found in both Japan and China as we have been constantly covering in all our recent COVID-19 News coverages.
 
Strangely there is no much mention of these new subvariants or sub-lineages in the mainstream media and instead certain media that are part of the BBC trusted News Initiative are disseminating fake news about the variants found in China and Japan.
https://www.ndtv.com/india-news/not-one-4-virus-variants-causing-china-surge-centres-covid-panel-chief-3643021
 
https://finance.yahoo.com/news/alternative-healthcare-activists-file-antitrust-162100012.html
 
What is also interesting is that preliminary data that is yet to be verified is showing that perhaps because of ADE or immunity imprinting, those who have already had the COVID-19 shots are more likely at an increased risk of infected or be impacted worse and likely to suffer disease severity and increased risk of mortality as result of getting infected with these new East Asian subvariants and sub-lineages!
 
Urgent studies are warranted on this.
 
Meanwhile there are lots of interesting developments taking place in Japan:
 
https://www.newswise.com/coronavirus/japan-s-lack-of-infectious-diseases-research-exposed-by-covid-19-pandemic/?article_id=784039
 
https://twitter.com/natfukue/status/1611578377789665283
 
https://twitter.com/WSWS_Healthcare/status/1612902098005331969
 
https://twitter.com/themainichi/status/1614095206428643330
 
https://twitter.com/UngaTheGreat/status/1613896633812647937
 
https://www.youtube.com/watch?v=zbmB19tp5aU&t=2s
 
https://www.trialsitenews.com/a/top-japanese-physician-scientists-give-dire-warning-about-covid-19-mrna-vaccines-scientifically-misconceived-09bab2eb
 
https://twitter.com/Aaron_Derfel/status/1614129446696402944
 
https://twitter.com/denisrancourt/status/1612536796130299904
 
https://halturnerradioshow.com/index.php/en/news-page/world/japan-launches-official-investigation-into-millions-of-covid-vaccine-deaths
 
https://twitter.com/2Hey_TwoBottle/status/1613033328986435585
 
https://www.stripes.com/theaters/asia_pacific/2023-01-12/civilian-health-care-japan-town-hall-8746162.html
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/covid-19-news-xbb-1-5-variant-which-is-more-transmissible-and-spreading-fast-will-not-wreak-much-havoc-as-compared-to-new-bf-and-ba-5-2-sublineages
 

MOST READ

Nov 05, 2024  18 days ago
Nikhil Prasad
Jul 25, 2024  4 months ago
Nikhil Prasad
Jul 24, 2024  4 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer